FASN and steatosis: Chambel et al.94 stated that activation of the nrf2 pathway prevents lipogenesis and stimulates fatty acid synthase (fas) β-oxidation to protect the liver from steatosis while inactivation of the nrf2 pathway may aggravate liver injury persuaded by hepatotoxicants6.